BEDFORD, Mass., April 23, 2014 /PRNewswire/ -- Hologic, Inc.
(Hologic or the Company) (NASDAQ: HOLX), a leading developer,
manufacturer and supplier of premium diagnostic products, medical
imaging systems and surgical products, with an emphasis on serving
the healthcare needs of women, will showcase its comprehensive
suite of healthcare solutions for women at the 62nd
Annual Clinical Meeting of the American College of Obstetricians
and Gynecologists (ACOG) on April
26th - 30th at the McCormick Place
Convention Center in Chicago. ACOG
is a professional association of medical doctors specializing in
obstetrics and gynecology in the United
States. It has a membership of over 55,000 and represents 90
percent of U.S. board-certified obstetrician-gynecologists.
"The ACOG annual clinical meeting attracts thousands of women's
health care providers from around the world," said Jon Gingrich, Hologic's Group Vice President,
Women's Health. "This meeting provides the perfect venue for
Hologic to showcase our extensive suite of gynecological products
and 3D mammography technology. Our market leading products assist
clinicians in addressing a wide range of women's health concerns
including sexually transmitted infections, cervical cancer,
abnormal uterine bleeding, and breast cancer. As a single-source
supplier of world-class imaging, diagnostic and surgical products,
we are dedicated to helping clinicians provide the highest quality
care to women throughout their life."
On display from Hologic's Diagnostics division will be the
ThinPrep and Aptima HPV cervical cancer screening
product lines. The Company will also highlight two minimally
invasive surgical products from its GYN Surgical Solutions division
that address abnormal uterine bleeding, a condition that affects 1
in 5 women in the United States.
The NovaSure endometrial ablation system, which has just
reached a milestone 2 million procedures performed worldwide,
offers women a clinically proven, safe and effective treatment
option for heavy periods. Hologic's MyoSure tissue removal
system is a minimally invasive hysteroscopic treatment for the
removal of intrauterine pathology including fibroids and polyps.
Also featured from the Company's GYN surgical product line will be
the Aquilex fluid control system, a high-performance
fluid pump and suction system designed to minimize the risk of
inaccurate deficit readings while maintaining constant uterine
cavity distention throughout the MyoSure procedure; and the
Tower-free Hysteroscopy System (THS), a versatile platform
designed to meet the diverse diagnostic and treatment needs of the
gynecologist's office.
Participants will have the opportunity to use Hologic's
GyneSim virtual simulation system, a platform for realistic
teaching and training of MyoSure procedures, when they visit
the Hologic booth.
The Company will also showcase images from its game-changing
Dimensions 3D mammography system on SecurView
diagnostic workstations. Both products are part of the Company's
Breast Health division. Hologic's 3D mammography technology is
clinically proven to increase invasive breast cancer detection
rates and reduce anxiety provoking and costly recalls. Hologic is
currently the only company to have an FDA approved 3D mammography
system and has over 1,500 systems installed worldwide.
Hologic is hosting a special luncheon symposium in the ACOG
product theater, "Cutting Edge Breast and Cervical Cancer
Screening: Maximizing Benefits, Minimizing Harm," on Tuesday, April 29th from 12 to 1:00 p.m. A panel of experts will address
the clinical benefits of Hologic's 3D mammography technology in
breast cancer screening and diagnosis and Hologic's Aptima
HPV assay, an mRNA-based screening test for cervical cancer
screening – and how these technologies can lead to more effective
screening strategies.
Hologic's game-changing technologies will be on display in booth
#601 in the West Building of McCormick Place.
About Hologic, Inc.:
Hologic, Inc. is a leading developer, manufacturer and supplier
of premium diagnostic products, medical imaging systems and
surgical products. The Company operates four core business units
focused on breast health, diagnostics, GYN surgical, and skeletal
health. With a comprehensive suite of technologies and a robust
research and development program, Hologic is committed to improving
lives. The Company is headquartered in Massachusetts. For more information, visit
www.Hologic.com.
Hologic, Aptima, Aquilex, Dimensions, MyoSure, NovaSure,
SecurView, THS, and ThinPrep are trademarks and/or registered
trademarks of Hologic, Inc., and/or its subsidiaries in
the United States and/or other
countries.
Forward-Looking Statement Disclaimer:
This News Release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic products. There can be no assurance these products
will achieve the benefits described herein and that such benefits
will be replicated in any particular manner with respect to an
individual patient as the actual effect of the use of the products
can only be determined on a case-by-case basis depending on the
particular circumstances and patient in question. Hologic expressly
disclaims any obligation or undertaking to release publicly any
updates or revisions to any such statements presented herein to
reflect any change in expectations or any change in events,
conditions or circumstances on which any such data or statements
are based.
Contacts:
|
|
|
|
Marianne
McMorrow
|
Jim Culley
|
Manager, Corporate
Communications
|
Senior
Director, Corporate Communications
|
Marianne.McMorrow@Hologic.com
|
Jim.Culley@Hologic.com
|
Tel: +1 781 999
7723
|
Tel: +1 781 999
7583
|
SOURCE Hologic, Inc.